Send the following on WhatsApp
Continue to ChatRedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study https://thebajapost.com/2021/06/08/redhill-biopharma-completes-enrollment-of-oral-opaganib-phase-2-3-covid-19-study/
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study https://thebajapost.com/2021/06/08/redhill-biopharma-completes-enrollment-of-oral-opaganib-phase-2-3-covid-19-study/